Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Follow Bar and Bench channel on WhatsApp

Download the Bar and Bench Mobile app for instant access to the latest legal news.

Also Read

Kunal Kamra and Senior Advocate Haresh Jagtiani move Bombay High Court against Sahyog portal

Compromising standards? Supreme Court "stunned" by reduction in NEET-PG 2025 cut-off

Allahabad High Court orders release of Wiztown director in Noida techie death case

Centre revises fees for its law officers; ₹1.20L monthly retainer for Attorney General, ₹96K for SG

NCLAT upholds CCI decision to close abuse of dominance case against NSE over co-location services

SCROLL FOR NEXT